| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pluri Inc. (PLUR) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 1 sell. PLUR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 625.0K | $2.10M | - | |
| CEO | 497.8K | $1.67M | - | |
| Dir | 144.2K | $483.4K | - | |
| CFO | 92.8K | $311.0K | - | |
| Dir | 19.1K | $64.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2016 | Yanay Yaky | CFO, COO &President | Buy | 5,000 | $1.20 | $6,000.00 | +8.1% | |
| Feb 16, 2016 | Aberman Zami | CEO &Chairman | Buy | 15,000 | $1.07 | $15,990.00 | +7.8% | |
| Feb 16, 2016 | Yanay Yaky | CFO, COO &President | Buy | 15,000 | $0.95 | $14,250.00 | +14.9% | |
| Feb 15, 2016 | Shorrer Doron | Director | Buy | 12,346 | $0.81 | $9,968.16 | +2.2% | |
| Feb 12, 2016 | Yanay Yaky | CFO, COO &President | Buy | 5,000 | $0.83 | $4,138.50 | +12.0% | |
| Feb 11, 2016 | Ben-Yoram Israel | Director | Buy | 10,000 | $0.79 | $7,900.00 | +4.9% | |
| Feb 11, 2016 | Aberman Zami | CEO &Chairman | Buy | 31,000 | $0.80 | $24,716.30 | +51.3% | |
| Nov 16, 2015 | Aberman Zami | CEO &Chairman | Buy | 9,900 | $1.49 | $14,751.00 | +19.6% | |
| Nov 16, 2015 | Yanay Yaky | CFO, COO &President | Buy | 10,000 | $1.52 | $15,200.00 | +31.7% | |
| Sep 21, 2015 | Ben-Yoram Israel | Director | Sell | 30,000 | $2.10 | $63,000.00 | -14.6% |